J. Behr (Munich, Germany), A. Fisher (Newcastle, United Kingdom)
Impact of pulmonary hypertension after lung transplantation on functional outcome
J. Englmeier, C. Neurohr, P. Huppmann, W. von Wulffen, G. Zimmermann, S. Leuschner, T. Meis, J. Behr (Munich, Germany)
|  |
Ion mobility spectrometry in lung transplant patients
U. Sommerwerck, O. Anhenn, B. Boedecker, J. Baumbach, H. Teschler (Dortmund, Germany)
|  |
Ion mobility spectrometry as diagnostic tool for bronchiolitis obliterans syndrome
U. Sommerwerck, O. Anhenn, K. Darwiche, J. Baumbach, B. Boedeker, F. Lutz, M. Kamler, H. Jakob, H. Teschler (Dortmund, Essen, Germany)
| |
The clinical relevance of mannose-binding lectin (MBL) in long term survival of lung transplant recipients
J. Kwakkel-van Erp, H. Otten, A. Paantjens, D. van Kessel, J. van den Bosch, J. Grutters, E. van de Graaf (Utrecht, Nieuwegein, Netherlands)
| |
Exhaled nitric oxide measured at different flow rates to detect early bronchiolitis obliterans syndrome after lung transplantation
M. Hofer, C. Benden, T. Rechsteiner, A. Boehler (Zuerich, Switzerland)
| |
Clinical characteristics and pulmonary function in patients with pulmonary fibrosis assessed for lung transplant
J. Ossés, R. Ahumada, G. Wagner, A. Bertolotti, R. Favaloro, J. Caneva (Buenos Aires, Argentina)
| |
Increased NKT cells are a major source of pro-inflammatory cytokines and granzymes in lung transplant patients
G. Hodge, S. Hodge, C. L. Liew, P. Reynolds, M. Holmes (Adelaide, Australia)
| |
T cell analyses in blood, BAL and induced sputum from lung transplant recipients
A. M. Holm, L. I. B. Sikkeland, T. B. Riste, M. B. Lund, O. Bjørtuft, J. Kongerud, N. Alexis (Oslo, Norway; Chapel Hill, United States Of America)
| |
Lung allocation score allows a more accurate evaluation of post transplant outcomes
M. M. Tuohy, D. Healy, W. Bartosik, J. McCarthy, A. E. Wood, J. J. Egan (Dublin, Ireland)
| |
Influenza A/H1N1 vaccination in lung a transplant program: Coverage, safety and clinical effectiveness during the pandemic 2009/2010
M. M. Schuurmans, L. Dalar, C. Benden, A. Boehler (Zurich, Switzerland)
| |
Exercise testing in paediatric lung tranplant candidates with cystic fibrosis
T. Radtke, A. Faro, J. Wong, A. Boehler, C. Benden (Zurich, Switzerland; St. Louis, United States Of America; Edmonton, Canada)
| |
Time course of functional recovery after lung transplantation; a one year follow-up
E. Blanken, I. vd Port, J. Trappenburg, H. Kwakkel-van Erp, E. van de Graaf (Utrecht, Netherlands)
| |
Antimicrobial properties of aerosolized liposomal cyclosporine (L-CsA) in lung transplantation patients – An in vitro study
J. Schierholz, A. Schwarzkopf, O. Denk, I. Fischer, M. Keller (Graefelfing, Aura an der Saale, Tuebingen, Germany)
| |
Dialysate-based perfusate of low viscosity is suitable for normothermic ex vivo lung perfusion
K. Noda, K. Kokubo, T. Shinbo, M. Hirose, H. Kobayashi (Sagamihara, Japan)
| |